• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[妊娠期活化蛋白C抵抗与深静脉血栓形成]

[Activated protein C resistance and deep venous thrombosis in pregnancy].

作者信息

Procházka M, Krcová V, Hrachovec P, Kudela M, Slavík L

机构信息

Porodnicko-gynekologická klinika FN a LF UP Olomouc.

出版信息

Ceska Gynekol. 2002 Sep;67(5):251-4.

PMID:12434659
Abstract

OBJECTIVE

The aim of the study was to detect the incidence of resistance to activated protein C in pregnant or puerperal women with confirmed diagnosis of deep venous thrombosis or pulmonary embolism.

DESIGN

Case-control study.

SETTING

Dept. of Obstetrics and Gynaecology, Dept. of Haemato-oncology, Medical Faculty, Palacky University, Olomouc.

METHODS

The group of 33 women with confirmed deep venous thrombosis were examined for resistance to activated C protein. The levels of C and S proteins, antithrombin III., prothrombin, heparin II cofactor and plasminogen were measured. Patient with APC ratio below 1.86, were tested by PCR analysis for the detection of the FV:Q506 allele. The control group had 51 pregnant women, chosen randomly. The statistical evaluation was performed by STATISTICA program. For the analyzing of the continuous variables the Students' T-test was used. For the categorical variables the chi 2 test was used (for comparison of 2 relative values). Values below P < 0.01 were considered to be statistically significant.

RESULTS

Women who have shown to suffer from deep venous thrombosis (DVT) came to the mean age of 31 +/- 3.1 years, weight 75.3 +/- 7.9 kg and BMI 28.7 +/- 4.3. All of the results above were rendered to be statistically significant. 54.5% of thrombosis occurred in the 3rd trimester, 61% were localised to the left iliofemoral vein. APC resistance appeared in 17 (51%) women with DVT, in comparison to 5 (9.8%) women in the control group (i.e. statistically significant). Factor V appeared in II (33.3%) women, in comparison to 3 (5.9%) women in the control group.

CONCLUSION

APC resistance and factor V. Leiden represent as important factors in the aetiology of deep venous thrombosis in pregnancy.

摘要

目的

本研究旨在检测确诊为深静脉血栓形成或肺栓塞的孕妇或产褥期妇女中对活化蛋白C产生抵抗的发生率。

设计

病例对照研究。

地点

奥洛穆茨帕拉茨基大学医学院妇产科、血液肿瘤学系。

方法

对33例确诊为深静脉血栓形成的女性进行活化C蛋白抵抗检测。检测C蛋白、S蛋白、抗凝血酶III、凝血酶原、肝素II辅因子和纤溶酶原的水平。APC比值低于1.86的患者通过PCR分析检测FV:Q506等位基因。对照组为51名随机选择的孕妇。采用STATISTICA程序进行统计评估。对于连续变量的分析,使用学生t检验。对于分类变量,使用卡方检验(用于比较两个相对值)。P值小于0.01被认为具有统计学意义。

结果

出现深静脉血栓形成(DVT)的女性平均年龄为31±3.1岁,体重75.3±7.9kg,BMI为28.7±4.3。上述所有结果均具有统计学意义。54.5%的血栓形成发生在孕晚期,61%位于左髂股静脉。17例(51%)DVT女性出现APC抵抗,而对照组为5例(9.8%)女性(即具有统计学意义)。FV Leiden出现在2例(33.3%)女性中,而对照组为3例(5.9%)女性。

结论

APC抵抗和FV Leiden是妊娠深静脉血栓形成病因中的重要因素。

相似文献

1
[Activated protein C resistance and deep venous thrombosis in pregnancy].[妊娠期活化蛋白C抵抗与深静脉血栓形成]
Ceska Gynekol. 2002 Sep;67(5):251-4.
2
[Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia].[子痫前期患者中因子V莱顿、凝血酶原及亚甲基四氢叶酸还原酶基因突变的发生情况]
Ceska Gynekol. 2003 May;68(3):162-6.
3
[Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].[深静脉血栓形成患者的活化蛋白C抵抗、莱顿突变、抗凝蛋白及纤维蛋白原水平]
Pol Arch Med Wewn. 2003 Jun;109(6):579-88.
4
Resistance to activated protein C--frequent etiologic factor for venous thrombosis.对活化蛋白C的抵抗——静脉血栓形成的常见病因
Bratisl Lek Listy. 2001;102(5):240-7.
5
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.对活化蛋白 C 的抵抗是妊娠相关静脉血栓形成的危险因素,而不存在 F5 rs6025(因子 V 莱顿)多态性。
Br J Haematol. 2011 Jul;154(2):241-7. doi: 10.1111/j.1365-2141.2011.08712.x. Epub 2011 May 12.
6
[Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].[活化蛋白C抵抗与静脉血栓形成倾向:德国人群的分子遗传学患病率研究]
Dtsch Med Wochenschr. 1999 Jun 25;124(25-26):783-7. doi: 10.1055/s-2007-1024412.
7
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.韩国深静脉血栓形成患者中活化蛋白C抵抗和凝血因子V Arg506至Gln突变的低患病率。
J Korean Med Sci. 1998 Dec;13(6):587-90. doi: 10.3346/jkms.1998.13.6.587.
8
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.遗传性血栓形成倾向与妊娠和产褥期首次静脉血栓栓塞症
Thromb Haemost. 2002 May;87(5):791-5.
9
Venous thromboembolism during pregnancy is not associated with persistent elevated activated protein C (APC) sensitivity ratio based on the endogenous thrombin potential.基于内源性凝血酶潜力,孕期静脉血栓栓塞与活化蛋白C(APC)敏感性比值持续升高无关。
Thromb Haemost. 2005 Feb;93(2):306-10. doi: 10.1160/TH04-06-0372.
10
[Adrenal vein thrombosis during pregnancy].
J Gynecol Obstet Biol Reprod (Paris). 2010 Feb;39(1):68-71. doi: 10.1016/j.jgyn.2009.09.012. Epub 2009 Nov 6.

引用本文的文献

1
Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients.因子V莱顿突变:黎巴嫩患者静脉血栓形成的常见风险因素。
Thrombosis. 2012;2012:380681. doi: 10.1155/2012/380681. Epub 2012 Jun 12.
2
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.获得性活化蛋白C抵抗、血栓形成倾向与不良妊娠结局:在爱尔兰孕妇队列中开展的一项研究
J Pregnancy. 2011;2011:232840. doi: 10.1155/2011/232840. Epub 2011 Aug 14.